PA
TVRD

Parallel Advisors’s Tvardi Therapeutics TVRD Stock Holding History

Parallel Advisors’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Hold
0
– – – 3630
2024
Q3 		– Hold
0
– – – 3395
2024
Q2 		– Hold
0
– – – 3313
2024
Q1 		– Hold
0
– – – 3283
2023
Q4 		– Hold
0
– – – 3303
2023
Q3 		– Sell
-2
Closed -$188 – 3344
2023
Q2 		$252 Buy
+2
New +$276 ﹤0.01% 3216
2023
Q1 		– Hold
0
– – – 3389
2022
Q4 		– Hold
0
– – – 3297
2022
Q3 		– Hold
0
– – – 3552
2022
Q2 		– Hold
0
– – – 3411
2022
Q1 		– Hold
0
– – – 3321
2021
Q4 		– Sell
-1
Closed -$502 – 3327
2021
Q3 		$1K Hold
1
– – ﹤0.01% 2988
2021
Q2 		$1K Hold
1
– – ﹤0.01% 2864
2021
Q1 		$1K Hold
1
– – ﹤0.01% 2723
2020
Q4 		$1K Hold
1
– – ﹤0.01% 2508
2020
Q3 		$1K Hold
1
– – ﹤0.01% 2514
2020
Q2 		$0 Buy
+1
New +$552 ﹤0.01% 2757
2020
Q1 		– Hold
0
– – – 2697
2019
Q4 		– Hold
0
– – – 2515
2019
Q3 		– Hold
0
– – – 2516
2019
Q2 		– Hold
0
– – – 2460
2019
Q1 		– Hold
0
– – – 2416
2018
Q4 		– Hold
0
– – – 2319
2018
Q3 		– Hold
0
– – – 2315
2018
Q2 		– Hold
0
– – – 2226
2017
Q2 		– Sell
-1
Closed -$1K – 2229
2017
Q1 		$1K Buy
+1
New +$534 ﹤0.01% 1933

Other funds holding TVRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Parallel Advisors's TVRD Position: Q4 2024 in Review

Parallel Advisors held its Tvardi Therapeutics (TVRD) position steady in Q4 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3630.

Parallel Advisors first reported a position in TVRD in Q1 2017 and has held it in 8 quarters since. The position peaked at $1K in Q3 2021. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.

  • Parallel Advisors held 0 shares of Tvardi Therapeutics worth $0 as of Q4 2024.
  • Parallel Advisors left its Tvardi Therapeutics share count unchanged in Q4 2024.
  • Tvardi Therapeutics made up ﹤0.01% of Parallel Advisors's portfolio in Q4 2024, its #3630 holding.
  • Parallel Advisors first reported a position in Tvardi Therapeutics in Q1 2017 and has held it in 8 quarters since.
  • Parallel Advisors's Tvardi Therapeutics position peaked at $1K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.